Translate this page into:
Original Article
PMID: 20877031
An open trial of pentoxifylline in schamberg's disease
Leishiowon Kumrah, Renu George, Soshamma George
,
Correspondence Address:
Leishiowon Kumrah
Correspondence Address:
Leishiowon Kumrah
| How to cite this article: Kumrah L, George R, George S. An open trial of pentoxifylline in schamberg's disease. Indian J Dermatol Venereol Leprol 2000;66:73-75 |
Copyright: (C)2000 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Fifteen patients with Schamberg's disease were enrolled in the study. Each patient was given 400mg of pentoxifylline once a day for 8 weeks. Skin biopsy was done in 6 patients to document the disease. Pretreatment and post treatment evaluation were made. There was no objective improvement in any of the patients though 4 reported subjective improvement in their pigmentation.
Keywords: Pentoxifylline, Schamberg′s disease, Purpura progressive pigmentary
